A human TRIM5α B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus

Felipe Diaz-Griffero, Michel Perron, Kathleen McGee-Estrada, Robert Hanna, Pierre V. Maillard, Didier Trono, Joseph Sodroski

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Human TRIM5α restricts N-tropic murine leukemia virus (N-MLV) but not B-tropic MLV (B-MLV) infection. Here we study B30.2/SPRY domain mutants of human TRIM5α that acquire the ability to inhibit B-MLV infection prior to reverse transcription without losing the ability to restrict N-MLV infection. Remarkably, these mutants gain the ability to decrease the amount of particulate B-MLV capsids in the cytosol of infected cells. In addition, these mutants gain the ability to restrict SIVmac and HIV-2 infection. B-MLV and SIVmac infections were blocked by the mutant TRIM5α proteins prior to reverse transcription. Thus, the range of retroviruses restricted by human TRIM5α can be increased by changes in the B30.2/SPRY domain, which also result in the ability to cause premature uncoating of the restricted retroviral capsid.

Original languageEnglish (US)
Pages (from-to)233-242
Number of pages10
JournalVirology
Volume378
Issue number2
DOIs
StatePublished - Sep 1 2008
Externally publishedYes

Fingerprint

Murine Leukemia Viruses
Capsid
Reverse Transcription
Infection
HIV-2
Virus Diseases
Mutant Proteins
Retroviridae
Cytosol
HIV Infections
B30.2-SPRY Domain

Keywords

  • Capsid
  • Mechanism
  • Restriction factor
  • Retrovirus
  • Reverse transcription
  • Tripartite motif
  • Uncoating

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

A human TRIM5α B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus. / Diaz-Griffero, Felipe; Perron, Michel; McGee-Estrada, Kathleen; Hanna, Robert; Maillard, Pierre V.; Trono, Didier; Sodroski, Joseph.

In: Virology, Vol. 378, No. 2, 01.09.2008, p. 233-242.

Research output: Contribution to journalArticle

Diaz-Griffero, Felipe ; Perron, Michel ; McGee-Estrada, Kathleen ; Hanna, Robert ; Maillard, Pierre V. ; Trono, Didier ; Sodroski, Joseph. / A human TRIM5α B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus. In: Virology. 2008 ; Vol. 378, No. 2. pp. 233-242.
@article{96eed26f5ad64c1cacf3f92fc67dd158,
title = "A human TRIM5α B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus",
abstract = "Human TRIM5α restricts N-tropic murine leukemia virus (N-MLV) but not B-tropic MLV (B-MLV) infection. Here we study B30.2/SPRY domain mutants of human TRIM5α that acquire the ability to inhibit B-MLV infection prior to reverse transcription without losing the ability to restrict N-MLV infection. Remarkably, these mutants gain the ability to decrease the amount of particulate B-MLV capsids in the cytosol of infected cells. In addition, these mutants gain the ability to restrict SIVmac and HIV-2 infection. B-MLV and SIVmac infections were blocked by the mutant TRIM5α proteins prior to reverse transcription. Thus, the range of retroviruses restricted by human TRIM5α can be increased by changes in the B30.2/SPRY domain, which also result in the ability to cause premature uncoating of the restricted retroviral capsid.",
keywords = "Capsid, Mechanism, Restriction factor, Retrovirus, Reverse transcription, Tripartite motif, Uncoating",
author = "Felipe Diaz-Griffero and Michel Perron and Kathleen McGee-Estrada and Robert Hanna and Maillard, {Pierre V.} and Didier Trono and Joseph Sodroski",
year = "2008",
month = "9",
day = "1",
doi = "10.1016/j.virol.2008.05.008",
language = "English (US)",
volume = "378",
pages = "233--242",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - A human TRIM5α B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus

AU - Diaz-Griffero, Felipe

AU - Perron, Michel

AU - McGee-Estrada, Kathleen

AU - Hanna, Robert

AU - Maillard, Pierre V.

AU - Trono, Didier

AU - Sodroski, Joseph

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Human TRIM5α restricts N-tropic murine leukemia virus (N-MLV) but not B-tropic MLV (B-MLV) infection. Here we study B30.2/SPRY domain mutants of human TRIM5α that acquire the ability to inhibit B-MLV infection prior to reverse transcription without losing the ability to restrict N-MLV infection. Remarkably, these mutants gain the ability to decrease the amount of particulate B-MLV capsids in the cytosol of infected cells. In addition, these mutants gain the ability to restrict SIVmac and HIV-2 infection. B-MLV and SIVmac infections were blocked by the mutant TRIM5α proteins prior to reverse transcription. Thus, the range of retroviruses restricted by human TRIM5α can be increased by changes in the B30.2/SPRY domain, which also result in the ability to cause premature uncoating of the restricted retroviral capsid.

AB - Human TRIM5α restricts N-tropic murine leukemia virus (N-MLV) but not B-tropic MLV (B-MLV) infection. Here we study B30.2/SPRY domain mutants of human TRIM5α that acquire the ability to inhibit B-MLV infection prior to reverse transcription without losing the ability to restrict N-MLV infection. Remarkably, these mutants gain the ability to decrease the amount of particulate B-MLV capsids in the cytosol of infected cells. In addition, these mutants gain the ability to restrict SIVmac and HIV-2 infection. B-MLV and SIVmac infections were blocked by the mutant TRIM5α proteins prior to reverse transcription. Thus, the range of retroviruses restricted by human TRIM5α can be increased by changes in the B30.2/SPRY domain, which also result in the ability to cause premature uncoating of the restricted retroviral capsid.

KW - Capsid

KW - Mechanism

KW - Restriction factor

KW - Retrovirus

KW - Reverse transcription

KW - Tripartite motif

KW - Uncoating

UR - http://www.scopus.com/inward/record.url?scp=49249129966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49249129966&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2008.05.008

DO - 10.1016/j.virol.2008.05.008

M3 - Article

VL - 378

SP - 233

EP - 242

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -